Christopher Michael Halloran

10.5k citations
118 papers · 7.5k · 4 hit papers · h-index 38

Impact in

Papers in

    • Pancreatic and Hepatic Oncology Research 58
    • Colorectal Cancer Screening and Detection 3
    • Pancreatitis Pathology and Treatment 33

Christopher Michael Halloran

114 papers receiving 7.4k citations

Christopher Michael Halloran's Hit Papers

Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial 2022 · 218 citations
2180+3+6Years since publication50010001.5k

Peers

Christopher Michael Halloran
Comparison fields: 5 of 142
  • Oncology 4.9k
  • Cancer Research 924
  • Surgery 2.4k
  • Pulmonary and Respiratory Medicine 1.0k
  • Gastroenterology 135
Replace Ching-Wei David Tzeng with:
Ching-Wei David Tzeng United States
Smitha Krishnamurthi United States
Marco Del Chiaro United States
Mahmoud M. Al-Hawary United States
Gabriela Verena Kornek Austria
Akihiko Tsuchida Japan
Stephen W. Behrman United States
Tobias Keck Germany
Carlos Fernández-del Castillo United States
Laëtitia Dahan France
Christopher Michael Halloran relative to Ching-Wei David Tzeng United States Ching-Wei David Tzeng's profile →
Citations per field
00.5×1.7×
Ching-Wei David Tzeng · 1×
Citations per year

Countries citing papers authored by Christopher Michael Halloran

Since Specialization
Citations

This map shows the geographic impact of Christopher Michael Halloran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Michael Halloran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Michael Halloran more than expected).

Fields of papers citing papers by Christopher Michael Halloran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Michael Halloran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Michael Halloran. The network helps show where Christopher Michael Halloran may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher Michael Halloran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Michael Halloran Line = papers co-authored together Christopher Michael Halloran links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
Hit paper breakdown →
20171516
2 2012457
3 2011418
4
Early detection of pancreatic cancer
Hit paper breakdown →
2020374
5
Acute Pancreatitis: Diagnosis and Treatment
Hit paper breakdown →
2022329
6 2013282
7 2004238
8 2017222
9
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial
Hit paper breakdown →
2022218
10 2010208
11 2019201
12 2017196
13 2016188
14 2018156
15 2002149
16 2017121
17 2021119
18 2018108
19 201196
20 201594

About Christopher Michael Halloran

Christopher Michael Halloran is a scholar working on Oncology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 118 papers that have together received 7.5k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (58 papers), Pancreatitis Pathology and Treatment (33 papers), Cancer Genomics and Diagnostics (10 papers), Neuroendocrine Tumor Research Advances (5 papers), Renal cell carcinoma treatment (4 papers), Phagocytosis and Immune Regulation (3 papers), Cancer Research and Treatments (3 papers) and Colorectal Cancer Screening and Detection (3 papers). The work is most often cited by research in Oncology (4.9k citations), Cancer Research (924 citations), Surgery (2.4k citations), Pulmonary and Respiratory Medicine (1.0k citations) and Gastroenterology (135 citations). Christopher Michael Halloran has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Paula Ghaneh, John P. Neoptolemos, Robert Sutton, Michael G.T. Raraty, Eithne Costello, William Greenhalf, Peter Szatmary, Wenhao Cai, Georg Beyer and Rajarshi Mukherjee. Their work appears in journals such as Pancreatology, Annals of Surgery, The Lancet, Surgery and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact